A class of ultrasmall fluorescent core-shell silica nanoparticles developed at Cornell is showing an unexpected ability to rally the immune system against melanoma and dramatically improve the ...

Bringing Decades of Successful Biotech Company Growth, Financing, IPO and M&A ExpertiseNORFOLK, Va.--(BUSINESS WIRE)--ReAlta ...

-- Proceeds to drive global Phase 3 trial for ASP-1929, targeting BLA submission to the U.S. FDA in 2028 -- Financing led by international life science fund TaiAx, with participation from the largest ...

Oncolytics Biotech® Inc. ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today announced the expansion of its gastrointestinal ("GI") Tumor Scientific ...

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune ...

New research from the University of Minnesota Medical School offers a new view of how the immune system responds to organ ...

The immune system’s first encounter with a virus or vaccine establishes a “starting template” that shapes its response to new ...

This review synthesizes clinical, genetic, and mechanistic evidence showing that suPAR and related uPAR fragments are ...

Learn which supplement is best for preventing and treating respiratory viruses, how to take them, and side effects to watch ...

Dr. Bo Rode Hansen, current Board member and Corporate Development Officer named Interim CEO Alex Blyth, Founder and CEO to ...

Please write a humorous but informative article for my All About Seniors column admitting that I’ve succumbed to a winter ...